相关实验视频
Updated: Jul 19, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
聚焦miR-647在人类癌症中不断扩大的作用
Mohammadmahdi Jalili1, Setayesh Tavakoli1, Kamran Kargar2
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Advanced biomedical research
|August 11, 2023
概括
像miR-647这样的微RNA是基因表达的关键调节者,并显示出作为癌症生物标志物的潜力. 异常的miR-647水平会影响各种癌症的瘤生长和患者的结果,这表明治疗价值.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 微RNAs (miRNAs) 是小型的非编码RNAs,通过表观遗传学来调节基因表达.
- miRNAs在细胞过程中起着至关重要的作用,并被认为是潜在的癌症生物标志物.
- 异常miRNA表达与包括癌症在内的各种人类疾病有关.
研究的目的:
- 审查分子机制,目标基因和miR-647在各种癌症中的临床意义.
- 巩固关于miR-647作为潜在生物标志物和瘤学治疗点的作用的证据.
主要方法:
- 在各种癌症类型中调查miR-647的研究的文献综述.
- 分析了关于miR-647表达水平,分子功能和临床影响的报告数据.
- 综合关于miR-647在瘤发生中的作用及其作为治疗点的潜力的发现.
主要成果:
- miR-647在许多癌症中表现出异常表达,包括膀,宫,结直肠,胃,质瘤,肝细胞,非小细胞肺癌,卵巢和前列腺癌.
- miR-647可以作为瘤基因或瘤抑制剂,影响癌细胞的增殖,迁移和入侵.
- 血清miR-647水平与整体存活率和疾病进展的降低相关.
结论:
- miR-647是各种癌症的重要调节剂,影响细胞循环路径和瘤进展.
- 作为癌症检测,预后和治疗反应评估的生物标志物,miR-647具有前景.
- 调节miR-647表达为固体瘤提供了潜在的治疗策略,抗瘤药物向其表达.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mouse Models of Cancer Study
5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

